Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference23 articles.
1. Recent trends in acute coronary heart disease-mortality, morbidity, medical care and risk factors. The Minnesota Heart Survey Investigators;McGovern;N Engl J Med,1996
2. Heart rate and cardiovascular mortality in the Framingham study;Kannel;Am Heart J,1987
3. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease;Diaz;Eur Heart J,2005
4. Risk stratification and survival following a myocardial infarction;N Engl J Med,1983
5. The relationships of left ventricular ejection fraction, end-diastolic index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis;Burns;J Am Coll Cardiol,2002
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Selective and brain-penetrant HCN1 inhibitors reveal links between synaptic integration, cortical function, and working memory;Cell Chemical Biology;2023-12
2. Sex differences in the generalizability of randomized clinical trials in heart failure with reduced ejection fraction;European Journal of Heart Failure;2023-05-18
3. Effect of Preoperative Ivabradine on Hemodynamics during Elective Off-Pump CABG;Annals of Cardiac Anaesthesia;2023
4. Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis;BMJ Evidence-Based Medicine;2021-11-17
5. Generalizability of randomized controlled trials in heart failure with reduced ejection fraction;European Heart Journal - Quality of Care and Clinical Outcomes;2021-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3